Cargando…
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial
Current antiviral treatment options for SARS-CoV-2 infections are not available globally, cannot be used with many medications, and are limited to virus-specific targets.(1–3) Biophysical modeling of SARS-CoV-2 replication predicted that protein translation is an especially attractive target for ant...
Autores principales: | Bramante, Carolyn T, Beckman, Kenneth B, Mehta, Tanvi, Karger, Amy B, Odde, David J, Tignanelli, Christopher J, Buse, John B, Johnson, Darrell M, Watson, Ray H. B., Daniel, Jerry J, Liebovitz, David M, Nicklas, Jacinda M, Cohen, Kenneth, Puskarich, Michael A, Belani, Hrishikesh K, Siegel, Lianne K, Klatt, Nichole R, Anderson, Blake, Hartman, Katrina M, Rao, Via, Hagen, Aubrey A, Patel, Barkha, Fenno, Sarah L, Avula, Nandini, Reddy, Neha V, Erickson, Spencer M, Fricton, Regina D., Lee, Samuel, Griffiths, Gwendolyn, Pullen, Matthew F, Thompson, Jennifer L., Sherwood, Nancy, Murray, Thomas A., Rose, Michael R., Boulware, David R, Huling, Jared D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275003/ https://www.ncbi.nlm.nih.gov/pubmed/37333243 http://dx.doi.org/10.1101/2023.06.06.23290989 |
Ejemplares similares
-
68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment.
por: Bramante, Carolyn, et al.
Publicado: (2023) -
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2
por: Avula, Nandini, et al.
Publicado: (2023) -
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
por: Bramante, Carolyn T., et al.
Publicado: (2022) -
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
por: Bramante, Carolyn T, et al.
Publicado: (2022) -
Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity
por: Bramante, Carolyn T., et al.
Publicado: (2021)